Literature DB >> 30120065

The Safety Level of Total Central Venous Access Port Implantation Performed by Residents.

Teresa Schreckenbach1, Indra Münch2, Hanan El Youzouri2, Wolf Otto Bechstein2, Nils Habbe3.   

Abstract

OBJECTIVE: The implantation of totally implantable venous access ports (TIVAPs) is one of the first procedures surgical residents learn. Complications after implantation procedures have a major impact on patient outcomes, as it may lead to a delay of chemotherapy regimens or of parenteral nutrition. The aim of this study was to compare the outcomes after totally implantable venous access ports implantations done by resident and attending surgeons.
DESIGN: The study was performed as a retrospective analysis.
SETTING: The study took place in primary care at the Department of General and Visceral Surgery at Frankfurt University Hospital. PARTICIPANTS: A total of 760 primary totally implantable venous access ports implantations performed between March 2008 and December 2016 were included in a database. Three groups of surgeons doing the implantations were defined: Group A (residents alone), Group B (resident with help), and Group C (attending surgeons).
RESULTS: There was a significant difference between the surgeon groups in operation time (p < 0.001). The groups differed between Group A (mean, 49; SD, 22) and Group C (mean, 39; SD, 20); p < 0.001) and Group B (mean, 53; SD, 23) and Group C (mean, 39; SD, 20; p < 0.001). The incidence of surgical site infections between Groups A and C (3.6% vs. 0.3%; p = 0.003) and Groups B and C (2.5% vs. 0.3%; p = 0.027) differed also significantly. Based on multivariable logistic regression analysis operation time in minutes (OR, 1.04; 95%CI, 1.03-1.06; p < 0.001) was an independent risk factor for any intraoperative complications. For any postoperative complications younger age of the patient (OR, 0.98; 95%CI, 0.97-0.99; p = 0.004) and benign primary disease (OR, 3.25; 95%CI, 1.55-6.64; p = 0.002) were independent risk factors based on multivariable regression analysis. Based on multivariable regression analysis a lower body mass index of the patient (OR, 0.93; 95%CI, 0.86-0.99; p = 0.044), benign primary disease (OR, 2.89; 95%CI, 1.07-7.79; p = 0.036), and no chemotherapy (OR, 3.55; 95%CI, 1.50-8.39; p = 0.004) were independent risk factors for postoperative catheter infections. Surgeon group was no risk factor, neither for intraoperative and postoperative complications, nor for catheter explantation due to complications.
CONCLUSION: Residents performing alone or residents performing with help can safely handle a central venous access port implantation. In patients with several risk factors, however, an attending should assist.
Copyright © 2018 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Patient Care; Practice-Based Learning and Improvement; Professionalism; education; patient care; resident involvement; resident participation

Mesh:

Year:  2018        PMID: 30120065     DOI: 10.1016/j.jsurg.2018.07.005

Source DB:  PubMed          Journal:  J Surg Educ        ISSN: 1878-7452            Impact factor:   2.891


  3 in total

1.  Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents.

Authors:  Keisuke Obuchi; Ken Imaizumi; Hiroyuki Kasajima; Michihiro Kurushima; Minoru Umehara; Yousuke Tsuruga; Daisuke Yamana; Kentaro Sato; Aya Sato; Shinsaku Suzuki; Kazuaki Nakanishi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons.

Authors:  Ryota Otsubo; Hiroshi Yano; Megumi Matsumoto; Aya Tanaka; Takashi Nonaka; Shigekazu Hidaka; Keitaro Matsumoto; Tomoshi Tsuchiya; Shuntaro Sato; Takeshi Nagayasu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Cephalic Vein Cut-down for Totally Implantable Central Venous Access Devices With Preoperative Ultrasonography by Surgical Residents.

Authors:  Shintaro Hashimoto; Ryota Otsubo; Masahiro Adachi; Ryoichiro Doi; Kenichiro Shibata; Isao Sano; Yoshihito Shibata; Takayuki Nakazaki; Hideki Taniguchi; Takeshi Nagayasu
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.